Literature DB >> 17172276

Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy.

Cordelia J Barrick1, Mauricio Rojas, Robert Schoonhoven, Susan S Smyth, David W Threadgill.   

Abstract

Left ventricular hypertrophy (LVH), a risk factor for cardiovascular morbidity and mortality, is commonly caused by essential hypertension. Three geometric patterns of LVH can be induced by hypertension: concentric remodeling, concentric hypertrophy, and eccentric hypertrophy. Clinical studies suggest that different underlying etiologies, genetic modifiers, and risk of mortality are associated with LVH geometric patterns. Since pressure overload-induced LVH can be modeled experimentally using transverse aortic constriction (TAC) and since C57BL/6J (B6) and 129S1/SvImJ (129S1) strains, which have different baseline cardiovascular phenotypes, are commonly used, we conducted serial echocardiographic studies to assess cardiac function up to 8 wk of post-TAC in male B6, 129S1, and B6129F1 (F1) mice. B6 mice had an earlier onset and more pronounced impairment in contractile function, with corresponding left and right ventricular dilatation, fibrosis, change in expression of hypertrophy marker, and increased liver weights at 5 wk of post-TAC. These observations suggest that B6 mice had eccentric hypertrophy with systolic dysfunction and right-sided heart failure. In contrast, we found that 129S1 and F1 mice delayed transition to decompensated heart failure, with 129S1 mice exhibiting preserved systolic function until 8 wk of post-TAC and relatively mild alterations in histology and markers of hypertrophy at 5 wk post-TAC. Consistent with concentric hypertrophy, our results show that these strains manifest different cardiac responses to pressure overload in a time-dependent manner and that genetic susceptibility to initial concentric hypertrophy is dominant to eccentric hypertrophy. These results also imply that genetic background differences can complicate interpretation of TAC studies when using mixed genetic backgrounds.

Entities:  

Mesh:

Year:  2006        PMID: 17172276     DOI: 10.1152/ajpheart.00816.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  68 in total

Review 1.  Tissue-Engineering for the Study of Cardiac Biomechanics.

Authors:  Stephen P Ma; Gordana Vunjak-Novakovic
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

2.  Protein kinase C binding protein 1 inhibits hypoxia-inducible factor-1 in the heart.

Authors:  Kathryn J Schunke; Chad B Walton; David R Veal; Chrisy T Mafnas; Cynthia D Anderson; Allison L Williams; Ralph V Shohet
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

3.  Longitudinal arrhythmogenic remodelling in a mouse model of longstanding pressure overload.

Authors:  M Boulaksil; M Noorman; M A Engelen; T A B van Veen; M A Vos; J M T de Bakker; H V M van Rijen
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

4.  Doppler estimation of reduced coronary flow reserve in mice with pressure overload cardiac hypertrophy.

Authors:  Craig J Hartley; Anilkumar K Reddy; Sridhar Madala; Lloyd H Michael; Mark L Entman; George E Taffet
Journal:  Ultrasound Med Biol       Date:  2008-02-06       Impact factor: 2.998

5.  Ultrasound based assessment of coronary artery flow and coronary flow reserve using the pressure overload model in mice.

Authors:  Wei-Ting Chang; Sudeshna Fisch; Michael Chen; Yiling Qiu; Susan Cheng; Ronglih Liao
Journal:  J Vis Exp       Date:  2015-04-13       Impact factor: 1.355

6.  Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling.

Authors:  Hsin-Yuan Cheng; Anping Dong; Manikandan Panchatcharam; Paul Mueller; Fanmuyi Yang; Zhenyu Li; Gordon Mills; Jerold Chun; Andrew J Morris; Susan S Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-20       Impact factor: 8.311

7.  Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.

Authors:  Jung Woo Han; Young Ho Lee; Su-In Yoen; Joel Abramowitz; Lutz Birnbaumer; Min Goo Lee; Joo Young Kim
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

8.  Hyperoxia-induced hypertrophy and ion channel remodeling in left ventricle.

Authors:  Siva K Panguluri; Jared Tur; Jutaro Fukumoto; Wei Deng; Kevin B Sneed; Narasaiah Kolliputi; Eric S Bennett; Srinivas M Tipparaju
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

9.  Low-dose dasatinib rescues cardiac function in Noonan syndrome.

Authors:  Jae-Sung Yi; Yan Huang; Andrea T Kwaczala; Ivana Y Kuo; Barbara E Ehrlich; Stuart G Campbell; Frank J Giordano; Anton M Bennett
Journal:  JCI Insight       Date:  2016-12-08

10.  Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice.

Authors:  Cordelia J Barrick; Reade B Roberts; Mauricio Rojas; Nalini M Rajamannan; Carolyn B Suitt; Kevin D O'Brien; Susan S Smyth; David W Threadgill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.